Published in Arthritis Rheum on February 01, 1990
Effect of Revival Soy on Fibromyalgia Pain | NCT00279942
Evaluation of Spa Therapy in the Treatment of Fibromyalgia (THERMALGI) | NCT02265029
Study of Gralise to Treat Fibromyalgia Patients (Gralise) | NCT02052414
Randomised Controlled Trial of Memantine in Fibromyalgia | NCT01653457
Fibromyalgia of Less Than One Year Duration. Study of Pregabalin | NCT01397006
Assessment of Central Pain in the Peripartum Period | NCT01291680
Frequency of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia | NCT01167413
Calcitonin in the Treatment of Fibromyalgia (CALFI) | NCT00754884
Web-based Education to Enhance Fibromyalgia Management | NCT00423631
Estrogen Receptor 1 Gene Polymorphism Frequency in Fibromyalgia Syndrome | NCT03786393
LDN and tDCS in Fibromyalgia | NCT04502251
Cannabidiol for Fibromyalgia (The CANNFIB Trial) (CANNFIB) | NCT04729179
Effectiveness of Dry Needling in Fibromyalgia Patients | NCT04942444
Microcurrent for Fibromyalgia | NCT04949100
Self Soft Tissue Therapy for Fibromyalgia Syndrome | NCT02881411
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet (2011) 7.90
A randomized trial of tai chi for fibromyalgia. N Engl J Med (2010) 4.37
The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity. J Rheumatol (2015) 3.75
An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord (2007) 3.71
Annual consultation prevalence of regional musculoskeletal problems in primary care: an observational study. BMC Musculoskelet Disord (2010) 3.07
Effectiveness of manual therapies: the UK evidence report. Chiropr Osteopat (2010) 2.93
Widespread body pain and mortality: prospective population based study. BMJ (2001) 2.85
Fibromyalgia syndrome: classification, diagnosis, and treatment. Dtsch Arztebl Int (2009) 2.85
Patient perspectives on the impact of fibromyalgia. Patient Educ Couns (2008) 2.57
Role of mechanical and psychosocial factors in the onset of forearm pain: prospective population based study. BMJ (2000) 2.56
Perceived intensity and unpleasantness of cutaneous and auditory stimuli: an evaluation of the generalized hypervigilance hypothesis. Pain (2009) 2.55
Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum (2010) 2.52
The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis (2001) 2.50
Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain (2013) 2.48
The MOBILIZE Boston Study: design and methods of a prospective cohort study of novel risk factors for falls in an older population. BMC Geriatr (2008) 2.42
[Definition, classification and diagnosis of fibromyalgia syndrome]. Schmerz (2008) 2.38
Fibromyalgia is not a rheumatologic disease anymore. Medscape J Med (2008) 2.35
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther (2009) 2.27
Oxytocin nasal spray in fibromyalgic patients. Rheumatol Int (2014) 2.22
Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality. Rheumatology (Oxford) (2009) 2.09
Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol (2010) 1.96
Frequency of fibromyalgia syndrome in breast cancer patients. Int J Clin Oncol (2012) 1.96
Evidence-Based Evaluation of Complementary Health Approaches for Pain Management in the United States. Mayo Clin Proc (2016) 1.94
Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol (2009) 1.87
The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract (2007) 1.84
Positive affect as a source of resilience for women in chronic pain. J Consult Clin Psychol (2005) 1.83
Issues in conducting epidemiologic research among elders: lessons from the MOBILIZE Boston Study. Am J Epidemiol (2008) 1.83
Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther (2013) 1.81
Antinuclear antibodies and breast implants. West J Med (1994) 1.77
Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain. Arthritis Rheum (2013) 1.76
Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum (2009) 1.76
Understanding fibromyalgia: lessons from the broader pain research community. J Pain (2009) 1.73
Fear of movement and avoidance behaviour toward physical activity in chronic-fatigue syndrome and fibromyalgia: state of the art and implications for clinical practice. Clin Rheumatol (2013) 1.72
Population study of tender point counts and pain as evidence of fibromyalgia. BMJ (1994) 1.71
Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis. PLoS One (2012) 1.71
Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum (2008) 1.71
2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag (2013) 1.70
Efficacy of different types of aerobic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther (2010) 1.67
Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract (2007) 1.67
The Research Diagnostic Criteria for Temporomandibular Disorders. I: overview and methodology for assessment of validity. J Orofac Pain (2010) 1.67
Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol Int (2008) 1.65
Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci (2006) 1.63
Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain (2011) 1.63
Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. Pain Med (2009) 1.60
Assessment of mechanisms in localized and widespread musculoskeletal pain. Nat Rev Rheumatol (2010) 1.59
The Southampton examination schedule for the diagnosis of musculoskeletal disorders of the upper limb. Ann Rheum Dis (2000) 1.56
Spatial summation of mechanically evoked muscle pain and painful aftersensations in normal subjects and fibromyalgia patients. Pain (2007) 1.56
Enhanced central pain processing of fibromyalgia patients is maintained by muscle afferent input: a randomized, double-blind, placebo-controlled study. Pain (2009) 1.55
A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyalgia. Arthritis Rheum (2008) 1.55
Early recognition of aortitis of the aorta ascendens with ¹⁸F-FDG PET/CT: syphilitic? Clin Rheumatol (2013) 1.55
Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol (2006) 1.54
A population-based twin study of functional somatic syndromes. Psychol Med (2008) 1.53
Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: a randomized, controlled pilot study. Pain (2011) 1.53
Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain (2007) 1.51
Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther (2006) 1.49
Effectiveness of physical activity in reducing pain in patients with fibromyalgia: a blinded randomized clinical trial. Rheumatol Int (2011) 1.49
Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Neuroimage (2009) 1.49
Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis (2002) 1.48
The science of fibromyalgia. Mayo Clin Proc (2011) 1.47
Pathophysiology of fibromyalgia. Am J Med (2009) 1.47
Fibromyalgia and disability adjudication: no simple solutions to a complex problem. Pain Res Manag (2014) 1.46
Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev (2015) 1.46
Efficacy of supervised exercise combined with transcutaneous electrical nerve stimulation in women with fibromyalgia: a prospective controlled study. Rheumatol Int (2012) 1.45
[Somatoform disorders with pain as the predominant symptom: results to distinguish a common group of diseases]. Schmerz (2009) 1.45
Couple perceptions of fibromyalgia symptoms: the role of communication. Pain (2013) 1.44
Traditional Chinese medicine diagnoses in a sample of women with fibromyalgia. Acupunct Med (2011) 1.44
Sex differences in musculoskeletal pain in older adults. Pain (2005) 1.44
Combining motivational and volitional strategies to promote unsupervised walking in patients with fibromyalgia: study protocol for a randomized controlled trial. Trials (2014) 1.42
Traditional Chinese Medicine for treatment of fibromyalgia: a systematic review of randomized controlled trials. J Altern Complement Med (2010) 1.41
Fear-learning deficits in subjects with fibromyalgia syndrome? Eur J Pain (2013) 1.41
Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men. Pain (2011) 1.41
Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil (2008) 1.41
The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatol Int (2015) 1.40
The association between fibromyalgia and carpal tunnel syndrome in the general population. Ann Rheum Dis (1996) 1.40
Is it necessary to strictly diagnose fibromyalgia syndrome in patients with chronic widespread pain? Clin Rheumatol (2015) 1.40
A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res (2010) 1.40
Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001. J R Soc Med (2004) 1.39
Fibromyalgia syndrome: metabolic and autophagic processes in intermittent cold stress mice. Pharmacol Res Perspect (2016) 1.39
Functional Somatic Syndromes: Emerging Biomedical Models and Traditional Chinese Medicine. Evid Based Complement Alternat Med (2004) 1.39
The PedsQL as a patient-reported outcome in children and adolescents with fibromyalgia: an analysis of OMERACT domains. Health Qual Life Outcomes (2007) 1.38
Reliability of heart period and systolic arterial pressure variabilities in women with fibromyalgia syndrome. Clin Rheumatol (2016) 1.38
Nerve conduction tests in patients with fibromyalgia: comparison with normal controls. Rheumatol Int (2003) 1.37
Prescribed exercise in people with fibromyalgia: parallel group randomised controlled trial. BMJ (2002) 1.37
Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis (1999) 1.34
Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc (2011) 1.33
Brain activity associated with slow temporal summation of C-fiber evoked pain in fibromyalgia patients and healthy controls. Eur J Pain (2008) 1.32
Reduced insular γ-aminobutyric acid in fibromyalgia. Arthritis Rheum (2012) 1.32
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. BMC Musculoskelet Disord (2011) 1.30
Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet Disord (2004) 1.27
Pain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J Acquir Immune Defic Syndr (2012) 1.27
Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network. Mol Pain (2012) 1.26
Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain. Curr Pain Headache Rep (2008) 1.26
[What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association]. Schmerz (2008) 1.26
Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics (2009) 1.26
Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Res Ther (2010) 1.25
Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol (2006) 1.25
Increased daily physical activity and fatigue symptoms in chronic fatigue syndrome. Dyn Med (2005) 1.25
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) Am J Ind Med (1996) 16.45
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
A controlled trial of teaching critical appraisal of the clinical literature to medical students. JAMA (1987) 14.20
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med (1991) 10.55
Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials (1995) 9.85
Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA (1994) 9.72
Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47
Systematic review of studies of quality of clinical care in general practice in the UK, Australia and New Zealand. Qual Health Care (2001) 8.83
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) (1998) 6.51
Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med (1995) 6.10
The fibromyalgia impact questionnaire: development and validation. J Rheumatol (1991) 5.94
Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56
A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns (1998) 5.40
Problems in the handling of clinical and research evidence by medical practitioners. Arch Intern Med (1983) 5.16
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. J Rheumatol (1997) 5.09
A critical appraisal of the efficacy of continuing medical education. JAMA (1984) 4.95
A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) (2003) 4.86
Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA (1998) 4.73
Post-Anaesthetic Complications in a Military Hospital. Can Med Assoc J (1942) 4.56
Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA (1994) 4.49
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45
A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42
Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol (1993) 4.39
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet (2000) 4.16
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med (1994) 3.96
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Health-related quality of life after knee replacement. J Bone Joint Surg Am (1998) 3.88
The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol (1998) 3.75
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Bacterial arthritis. N Engl J Med (1985) 3.61
Dynamics of neuronal interactions in monkey cortex in relation to behavioural events. Nature (1995) 3.59
Out of hours primary care centres: characteristics of those attending and declining to attend. BMJ (1994) 3.52
The bimodal mortality pattern of systemic lupus erythematosus. Am J Med (1976) 3.47
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (2008) 3.45
Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr (1999) 3.45
Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res (1996) 3.40
The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med (1995) 3.39
Assessing the quality of randomized controlled trials. Current issues and future directions. Int J Technol Assess Health Care (1996) 3.37
Disabling fibromyalgia: appearance versus reality. J Rheumatol (1993) 3.34
Effect of luminal growth factor preservation on intestinal growth. Lancet (1993) 3.25
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
The Ottawa patient decision aids. Eff Clin Pract (1999) 3.22
Raised ESR in polymyalgia rheumatica no longer a sine qua non? Lancet (1996) 3.20
Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventive hormone therapy. Med Decis Making (1998) 3.18
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Am J Med (1976) 3.07
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
The measurement iterative loop: a framework for the critical appraisal of need, benefits and costs of health interventions. J Chronic Dis (1985) 2.96
Corn pollen deposition on milkweeds in and near cornfields. Proc Natl Acad Sci U S A (2001) 2.94
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol (1997) 2.92
The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am (1993) 2.85
Combination therapy in rheumatoid arthritis: updated systematic review. Br J Rheumatol (1998) 2.77
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc Natl Acad Sci U S A (1984) 2.74
What do we know about the reliability and validity of physical examination tests used to examine the upper extremity? J Hand Surg Am (1999) 2.65
Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev (2002) 2.65
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52
Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol (1990) 2.50
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun (2005) 2.47
ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost (2007) 2.38
Does strengthening the abdominal muscles prevent low back pain--a randomized controlled trial. J Rheumatol (1999) 2.35
Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33
The International Clinical Epidemiology Network (INCLEN): a progress report. J Clin Epidemiol (1991) 2.32
Acute arthritis caused by gram-negative bacilli: a clinical characterization. Medicine (Baltimore) (1974) 2.25
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl (1994) 2.23
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum (1997) 2.23
Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol (1995) 2.23
Defining and investigating occupational asthma: a consensus approach. Occup Environ Med (2006) 2.22
Setting educational priorities for learning the concepts of population health. Med Educ (1989) 2.19
Fibromyalgia syndrome: new research on an old malady. BMJ (1989) 2.18
Physiological aspects of information processing in the basal ganglia of normal and parkinsonian primates. Trends Neurosci (1998) 2.17
Non-Hodgkin's lymphoma in patients with rheumatoid arthritis treated with low dose methotrexate. J Rheumatol (1996) 2.15
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14
A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage (2002) 2.14
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onside. CMAJ (1998) 2.12